Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates (Q42225564)
Jump to navigation
Jump to search
scientific article published on 10 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates |
scientific article published on 10 April 2014 |
Statements
1 reference
Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates (English)
1 reference
1 reference
1 reference
Darren A Murrey
1 reference
Bartholomew J Naughton
1 reference
F Jason Duncan
1 reference
Aaron S Meadows
1 reference
Tierra A Ware
1 reference
Katie J Campbell
1 reference
William G Bremer
1 reference
Christopher M Walker
1 reference
Laurie Goodchild
1 reference
Brad Bolon
1 reference
Krista La Perle
1 reference
Douglas M McCarty
1 reference
Haiyan Fu
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference